Accolade Other Current Liab vs Current Deferred Revenue Analysis

ACCD Stock

USD 3.22 0.14 4.17%

Accolade financial indicator trend analysis is way more than just evaluating Accolade prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Accolade is a good investment. Please check the relationship between Accolade Other Current Liab and its Current Deferred Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.

Other Current Liab vs Current Deferred Revenue

Other Current Liab vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Accolade Other Current Liab account and Current Deferred Revenue. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Accolade's Other Current Liab and Current Deferred Revenue is 0.92. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Accolade, assuming nothing else is changed. The correlation between historical values of Accolade's Other Current Liab and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Accolade are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Other Current Liab i.e., Accolade's Other Current Liab and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.92

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Other Current Liab

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Accolade's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Accolade current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.At present, Accolade's Sales General And Administrative To Revenue is projected to slightly decrease based on the last few years of reporting.

	2023	2024 (projected)
Depreciation And Amortization	50.6M	27.4M
Interest Income	229.5K	218.0K

Depreciation And Amortization Interest Income

Accolade fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Inventory	Other Current Assets
Total Assets		0.88	0.95	0.96	0.97	-0.8	0.37	0.71	0.92	-0.16	-0.73	0.86	0.79	0.93	0.84	0.3	0.88	0.81	0.95	0.91	0.81	0.89	0.32	0.9	0.65	0.86
Short Long Term Debt Total	0.88		0.94	0.9	0.95	-0.73	0.71	0.36	0.85	-0.57	-0.65	0.87	0.98	0.65	0.82	0.46	1.0	0.98	0.79	0.98	0.55	0.98	-0.13	0.83	0.74	0.77
Other Current Liab	0.95	0.94		0.99	0.96	-0.81	0.43	0.62	0.92	-0.28	-0.84	0.97	0.86	0.8	0.95	0.21	0.94	0.88	0.91	0.93	0.79	0.97	0.13	0.95	0.59	0.93
Total Current Liabilities	0.96	0.9	0.99		0.93	-0.8	0.35	0.68	0.96	-0.18	-0.86	0.94	0.81	0.85	0.93	0.15	0.9	0.83	0.91	0.91	0.84	0.92	0.27	0.95	0.62	0.94
Total Stockholder Equity	0.97	0.95	0.96	0.93		-0.81	0.54	0.56	0.88	-0.37	-0.68	0.87	0.9	0.83	0.83	0.44	0.95	0.91	0.9	0.96	0.68	0.95	0.09	0.88	0.67	0.81
Other Liab	-0.8	-0.73	-0.81	-0.8	-0.81		-0.25	-0.44	-0.8	0.18	0.72	-0.74	-0.71	-0.69	-0.73	-0.28	-0.73	-0.73	-0.68	-0.76	-0.6	-0.74	-0.12	-0.87	-0.27	-0.7
Net Tangible Assets	0.37	0.71	0.43	0.35	0.54	-0.25		-0.33	0.35	-0.96	0.02	0.34	0.82	0.03	0.25	0.78	0.71	0.79	0.2	0.67	-0.18	0.61	-0.66	0.23	0.69	0.13
Property Plant And Equipment Net	0.71	0.36	0.62	0.68	0.56	-0.44	-0.33		0.59	0.54	-0.72	0.61	0.17	0.89	0.66	-0.33	0.36	0.21	0.85	0.4	0.96	0.45	0.79	0.68	0.22	0.78
Current Deferred Revenue	0.92	0.85	0.92	0.96	0.88	-0.8	0.35	0.59		-0.19	-0.78	0.83	0.79	0.81	0.82	0.21	0.86	0.8	0.81	0.89	0.76	0.84	0.31	0.88	0.7	0.85
Net Debt	-0.16	-0.57	-0.28	-0.18	-0.37	0.18	-0.96	0.54	-0.19		-0.13	-0.23	-0.7	0.19	-0.15	-0.76	-0.57	-0.68	0.02	-0.5	0.37	-0.48	0.82	-0.09	-0.49	0.02
Retained Earnings	-0.73	-0.65	-0.84	-0.86	-0.68	0.72	0.02	-0.72	-0.78	-0.13		-0.89	-0.52	-0.7	-0.9	0.32	-0.65	-0.56	-0.79	-0.66	-0.88	-0.73	-0.34	-0.94	-0.23	-0.95
Accounts Payable	0.86	0.87	0.97	0.94	0.87	-0.74	0.34	0.61	0.83	-0.23	-0.89		0.76	0.72	1.0	0.06	0.87	0.81	0.86	0.83	0.79	0.95	0.09	0.93	0.44	0.96
Cash	0.79	0.98	0.86	0.81	0.9	-0.71	0.82	0.17	0.79	-0.7	-0.52	0.76		0.52	0.7	0.58	0.98	1.0	0.65	0.96	0.37	0.92	-0.28	0.74	0.74	0.63
Non Current Assets Total	0.93	0.65	0.8	0.85	0.83	-0.69	0.03	0.89	0.81	0.19	-0.7	0.72	0.52		0.73	0.1	0.65	0.54	0.94	0.7	0.9	0.68	0.62	0.8	0.5	0.8
Non Currrent Assets Other	0.84	0.82	0.95	0.93	0.83	-0.73	0.25	0.66	0.82	-0.15	-0.9	1.0	0.7	0.73		0.0	0.82	0.75	0.86	0.78	0.83	0.91	0.16	0.92	0.38	0.97
Other Assets	0.3	0.46	0.21	0.15	0.44	-0.28	0.78	-0.33	0.21	-0.76	0.32	0.06	0.58	0.1	0.0		0.46	0.55	0.08	0.43	-0.28	0.35	-0.45	0.01	0.51	-0.13
Long Term Debt	0.88	1.0	0.94	0.9	0.95	-0.73	0.71	0.36	0.86	-0.57	-0.65	0.87	0.98	0.65	0.82	0.46		0.98	0.79	0.99	0.55	0.98	-0.13	0.83	0.74	0.77
Cash And Short Term Investments	0.81	0.98	0.88	0.83	0.91	-0.73	0.79	0.21	0.8	-0.68	-0.56	0.81	1.0	0.54	0.75	0.55	0.98		0.68	0.97	0.41	0.94	-0.27	0.77	0.71	0.68
Net Receivables	0.95	0.79	0.91	0.91	0.9	-0.68	0.2	0.85	0.81	0.02	-0.79	0.86	0.65	0.94	0.86	0.08	0.79	0.68		0.8	0.9	0.83	0.41	0.89	0.53	0.91
Common Stock Total Equity	0.91	0.98	0.93	0.91	0.96	-0.76	0.67	0.4	0.89	-0.5	-0.66	0.83	0.96	0.7	0.78	0.43	0.99	0.97	0.8		0.58	0.94	-0.04	0.85	0.77	0.77
Common Stock Shares Outstanding	0.81	0.55	0.79	0.84	0.68	-0.6	-0.18	0.96	0.76	0.37	-0.88	0.79	0.37	0.9	0.83	-0.28	0.55	0.41	0.9	0.58		0.64	0.66	0.84	0.3	0.92
Long Term Debt Total	0.89	0.98	0.97	0.92	0.95	-0.74	0.61	0.45	0.84	-0.48	-0.73	0.95	0.92	0.68	0.91	0.35	0.98	0.94	0.83	0.94	0.64		-0.08	0.87	0.62	0.86
Non Current Liabilities Total	0.32	-0.13	0.13	0.27	0.09	-0.12	-0.66	0.79	0.31	0.82	-0.34	0.09	-0.28	0.62	0.16	-0.45	-0.13	-0.27	0.41	-0.04	0.66	-0.08		0.23	0.05	0.33
Capital Surpluse	0.9	0.83	0.95	0.95	0.88	-0.87	0.23	0.68	0.88	-0.09	-0.94	0.93	0.74	0.8	0.92	0.01	0.83	0.77	0.89	0.85	0.84	0.87	0.23		0.4	0.94
Inventory	0.65	0.74	0.59	0.62	0.67	-0.27	0.69	0.22	0.7	-0.49	-0.23	0.44	0.74	0.5	0.38	0.51	0.74	0.71	0.53	0.77	0.3	0.62	0.05	0.4		0.41
Other Current Assets	0.86	0.77	0.93	0.94	0.81	-0.7	0.13	0.78	0.85	0.02	-0.95	0.96	0.63	0.8	0.97	-0.13	0.77	0.68	0.91	0.77	0.92	0.86	0.33	0.94	0.41

Click cells to compare fundamentals

Accolade Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft

When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports:

How To Invest In Accolade

Details

Is Accolade Stock a good investment?

Details

What is Accolade's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.02)

Revenue Per Share

5.706

Quarterly Revenue Growth

0.098

Return On Assets

(0.07)

Return On Equity

(0.19)

The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Accolade Other Current Liab vs Current Deferred Revenue Analysis

Other Current Liab vs Current Deferred Revenue

Other Current Liab vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Other Current Liab

Current Deferred Revenue

Accolade fundamental ratios Correlations

Accolade Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Currrent Assets Other	+ 1.0	Accounts Payable
Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Common Stock Total Equity	+ 0.99	Long Term Debt
Cash	+ 0.98	Short Long Term Debt Total

Net Debt	- 0.96	Net Tangible Assets
Other Current Assets	- 0.95	Retained Earnings
Capital Surpluse	- 0.94	Retained Earnings
Non Currrent Assets Other	- 0.9	Retained Earnings
Accounts Payable	- 0.89	Retained Earnings
Common Stock Shares Outstanding	- 0.88	Retained Earnings